Candin

Biological Nielsen BioSciences, Inc.
Total Payments
$4.2M
Transactions
53
Doctors
33
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $3.3M 24 24
2023 $21,100 1 1
2021 $2,688 1 1
2019 $120,113 2 2
2018 $191,628 12 12
2017 $598,892 13 13

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $4.2M 53 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
CFW-3A Nielsen BioSciences, Inc. $3.3M 24
CFW-2D Nielsen BioSciences, Inc. $635,390 13
CAN2003 Nielsen BioSciences, Inc. $277,932 1

Top Doctors Receiving Payments for Candin — Page 2

Doctor Specialty Location Total Records
, D.O General Practice Phoenix, AZ $39,270 1
, M.D Specialist Salt Lake City, UT $36,854 2
, M.D Dermatology Lynchburg, VA $24,066 1
, MD Dermatology Pflugerville, TX $22,231 1
, DO Family Medicine Berlin, NJ $10,747 1
, M.D Dermatology Rogers, AR $9,430 2
, MD Dermatology Newport Beach, CA $4,805 2
, MD Urology Watertown, MA $4,100 2

About Candin

Candin is a biological associated with $4.2M in payments to 33 healthcare providers, recorded across 53 transactions in the CMS Open Payments database. The primary manufacturer is Nielsen BioSciences, Inc..

Payment data is available from 2017 to 2024. In 2024, $3.3M was paid across 24 transactions to 24 doctors.

The most common payment nature for Candin is "Unspecified" ($4.2M, 100.0% of total).

Candin is associated with 3 research studies, including "CFW-3A" ($3.3M).